The Cooper Companies, Inc. (NASDAQ:COO) Stake Lessened by Congress Wealth Management LLC DE

Congress Wealth Management LLC DE decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 159,116 shares of the medical device company’s stock after selling 1,907 shares during the period. Congress Wealth Management LLC DE owned 0.08% of Cooper Companies worth $14,628,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Cooper Companies in the 4th quarter worth $691,000. Highland Capital Management LLC acquired a new position in Cooper Companies during the fourth quarter worth about $4,004,000. Caprock Group LLC bought a new stake in Cooper Companies in the fourth quarter worth about $282,000. Franklin Resources Inc. lifted its holdings in Cooper Companies by 194.0% in the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after acquiring an additional 32,260 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after purchasing an additional 14,687 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

COO has been the topic of a number of research reports. Robert W. Baird dropped their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Stifel Nicolaus decreased their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Finally, Citigroup reduced their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Up 2.9 %

NASDAQ:COO opened at $84.07 on Tuesday. The business’s fifty day moving average price is $89.90 and its 200 day moving average price is $97.88. The firm has a market capitalization of $16.81 billion, a price-to-earnings ratio of 43.11, a PEG ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.